Whitehead
New president for ABPI
February 9, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Amgen, Pfizer, Whitehead, emms, john kearney
The Association of the British Pharmaceutical Industry has appointed John Kearney as its new president. Stepping into the role in …
AstraZeneca dives into gene editing
January 29, 2015Research and Development, Sales and Marketing AstraZeneca, Intellia Therapetics, Novartis, Thermo Fisher Scientific, Wellcome Trust Sanger Institute in Cambridge, Whitehead, broad institute, crispr, the Innovative Genomics Initiative in California
AstraZeneca is looking to harness the power of a pioneering genome-editing tool in a series of new collaborations. The UK …
Visions for the future: FT pharma and biotech event
December 19, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, ABPI, Deloitte, Medidata, Whitehead, financial ties, freeman, ft pharma
The FT Global Pharmaceutical and Biotechnology Conference held in London recently asked: “What will the life science company of the …
PPRS scheme payment percentage to rise by 6.62% in 2015
December 12, 2014Sales and Marketing ABPI, PPRS, VBP, Whitehead, government, medicines bill
The amount of payment due from pharma via the PPRS scheme for next year has been confirmed by the Department …
ABPI director jumps ship to EFPIA
December 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EFPIA, Whitehead, andrew powrie-smith, andrew-powrie-smith
ABPI director Andrew Powrie-Smith is leaving the body to join The European Federation of Pharmaceutical Industries and Associations (EFPIA) as …
UK budget sees R&D tax credits rise
December 3, 2014Sales and Marketing Budget, Cameron, George Osborne, NHS, Whitehead, life sciences
Chancellor George Osborne has delivered the government’s 2014 Autumn Statement to the Commons which includes news of an increase in …
NICE releases ‘person-centred’ medicines optimisation guidelines
October 14, 2014Research and Development, Sales and Marketing ABPI, NHS, NICE, UK, WHO, Whitehead
NICE has recently released the draft of its first guidance on medicines optimisation that it hopes will be more person-centered …
ABPI and BIA establish new manufacturing partnership
September 23, 2014Manufacturing and Production, Sales and Marketing ABPI, Actavis, AstraZeneca, BIA, Eisai, Fujifilm Diosynth Biotechnologies, GlaxoSmithKline, Knowledge Transfer Network (KTN), Oxford BioMedica, Pfizer, Whitehead, bates, mmip
The ABPI and the Bioindustry Association (BIA) have jointly established a new Medicines Manufacturing Industry Partnership (MMIP) to boost medicines …
Deepak Khanna: the legacy of an outgoing ABPI president
March 31, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Deepak Khanna, NHS, VBP, Whitehead, apbi, jonathan emms
You’d be forgiven for thinking that Deepak Khanna, the man who has overseen the activities of the ABPI for the …
ABPI: NHS must explain drugs take-up
January 22, 2014Sales and Marketing ABPI, NHS, NICE, Whitehead
The ABPI has called on the NHS to explain what it says is the ‘substantial variation’ in NHS patients’ access …
Pfizer head to be ABPI president
December 4, 2013Medical Communications, Sales and Marketing ABPI, MSD, PPRS, Pfizer, Whitehead, emms, khanna
The UK managing director of Pfizer Jonathan Emms is to replace Deepak Khanna as the ABPI president from April next …
New ABPI director of communications announced
June 17, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, Meadden, Whitehead
The ABPI has appointed its head of Policy and Public Affairs Catherine Meaden to be the organisation’s new director of …
‘No consensus’ on transparency
April 22, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, Goldacre, Whitehead, all trials, transparency
An ABPI meeting on increasing the transparency of the way clinical trials are reported has thrown up more questions than …
Ben Goldacre versus Stephen Whitehead – PharmaTimes Debate
February 27, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BMJ, Bad pharma, Cochrane, Goldacre, Whitehead
In the end, the ‘head to head’ between the UK’s most high profile critic of the pharma industry and ABPI …
NICE hits back at ‘limited’ EC study
January 28, 2013Sales and Marketing ABPI, EC, NHS, NICE, QALY, Whitehead
NICE has delivered a robust defence of the methods by which it arrives at a judgment on the value of …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
